Neutralizing Antibody Responses After Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted by Nirmatrelvir/Ritonavir Treatment is a research paper published in Open Forum Infectious Diseases (2023). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: AI036214
National Institutes of Health
Grant: AI131385
National Institutes of Health
Grant: CA177322
National Institutes of Health
Grant: DA039562
National Institutes of Health
Grant: DA046171
National Institutes of Health
Grant: AI125103
San Diego Center for AIDS Research
Grant: AI100665
NIH
Grant: K08 AI130381
NIH
Grant: DA049644
NIH
Grant: AI145555
NIH
Grant: MH128153
NIH
Grant: AI106039
NIH
Grant: DP2 CA051915
Burroughs Wellcome Fund
Career Award for Medical Scientists
Department of Veterans Affairs
James B. Pendleton Charitable Trust
John and Mary Tu Foundation
FWCI
1.18
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals